Export 2732 results:
Author Title Type [ Year(Asc)]
1997
S. E. K. Donalds LA, “Risk factors for mortality in infants and young children on dialysis: A report of the North American Renal Transplant Cooperative Study (NAPRTCS),”, 1997.
E. M, “Risk factors for preeclampsia in healthy nulliparous women,”, 1997.
E. M, “Risk factors for preeclampsia in healthy nulliparous women.”, Am J Obstet Gynecol, vol. 177, pp. 1003-10, 1997.
S. DM, “Risk factors for vascular thrombosis in pediatric renal transplantation: a special report of the North American Pediatric Renal Transplant Cooperative Study,”, Transplantation., vol. 63, pp. 1263-67, 1997.
A. Singh, Stablein, D., and Tejani, A., “Risk factors for vascular thrombosis in pediatric renal transplantation: a special report of the North American Pediatric Renal Transplant Cooperative Study.”, Transplantation, vol. 63, no. 9, pp. 1263-7, 1997.
B. J. Vena D, “The risk of secondary malignancies following purine analog therapy of chronic lymphocytic leukemia (CLL) and hairy cell leukemia (HCL).”, Proc ASCO., p. 52, 1997.
S. DM, “Safety of kidney biopsy in pediatric transplantation: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS),”, 1997.
W. M, “Safety profile of Phase I and II preventive HIV tTpe 1 envelope vaccination: experience of the NIAID AIDS Vaccine Evaluation Group,”, AIDS Res Hum Retroviruses, vol. 13, pp. 1163-77, 1997.
M. C. Keefer, Wolff, M., Gorse, G. J., Graham, B. S., Corey, L., Clements-Mann, M. L., Verani-Ketter, N., Erb, S., Smith, C. M., Belshe, R. B., Wagner, L. J., McElrath, M. J., Schwartz, D. H., and Fast, P., “Safety profile of phase I and II preventive HIV type 1 envelope vaccination: experience of the NIAID AIDS Vaccine Evaluation Group.”, AIDS Res Hum Retroviruses, vol. 13, no. 14, pp. 1163-77, 1997.
A. R, “Sample-path insensitivity of symmetric queues in discrete-time.”, Nonlinear Analysis: Theory, Methods, and Applications, vol. 30, pp. 1099-110, 1997.
V. DA, “Treatment of refractory chronic lymphocytic leukemia with fludarabine phosphate via the group C protocol mechanism of the National Cancer Institute; 5-year follow-up report,”, J Clin Oncol, vol. 15, 1997.
J. M. Sorensen, Vena, D. A., Fallavollita, A., Chun, H. G., and Cheson, B. D., “Treatment of refractory chronic lymphocytic leukemia with fludarabine phosphate via the group C protocol mechanism of the National Cancer Institute: five-year follow-up report.”, J Clin Oncol, vol. 15, no. 2, pp. 458-65, 1997.
R. J. Levine, Hauth, J. C., Curet, L. B., Sibai, B. M., Catalano, P. M., Morris, C. D., DerSimonian, R., Esterlitz, J. R., Raymond, E. G., Bild, D. E., Clemens, J. D., and Cutler, J. A., “Trial of calcium to prevent preeclampsia.”, N Engl J Med, vol. 337, no. 2, pp. 69-76, 1997.
C. TE, “Validity of JVA interpretation in conjunction with RDC history & clinical examination to assess TMD,”, 1997.
S. EK, “Varicella in the first year after renal transplantation: A report of the North American Pediatric Renal Transplant Cooperative Study.”, Pediatr Transpl., vol. 1, pp. 37-42, 1997.
S. L. Furth, Sullivan, E. K., Neu, A. M., Tejani, A., and Fivush, B. A., “Varicella in the first year after renal transplantation: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS).”, Pediatr Transplant, vol. 1, no. 1, pp. 37-42, 1997.
S. EK, “Varicella requiring hospitalization in the first year after renal transplantation: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS),”, 1997.
1996
D. LG, “AIDS dementia complex in the Italian National AIDS Registry: temporal trends (1987-93) and differential incidence according to mode of transmission of HIV-1 infection,”, J Neurol Sci, vol. 144 (1-2), pp. 107-13, 1996.
A. Chiesi, Seeber, A. C., Dally, L. G., Floridia, M., Rezza, G., and Vella, S., “AIDS dementia complex in the Italian National AIDS Registry: temporal trends (1987-93) and differential incidence according to mode of transmission of HIV-1 infection.”, J Neurol Sci, vol. 144, no. 1-2, pp. 107-13, 1996.
S. EK, “Alternate-day steroid dosing improves growth without adversely affecting graft survival or long-term graft function,”, Transplantation, vol. 61, pp. 31-36, 1996.
K. Jabs, Sullivan, E. K., Avner, E. D., and Harmon, W. E., “Alternate-day steroid dosing improves growth without adversely affecting graft survival or long-term graft function. A report of the North American Pediatric Renal Transplant Cooperative Study.”, Transplantation, vol. 61, no. 1, pp. 31-6, 1996.
M. I. MJ, “Are you trained to locate the tender points?,”, 1996.
S. DM, “Beneficial effect on non-inherited maternal antigens on graft survival in pediatric renal transplantation,”, J Am Soc Nephrol, vol. 7, p. 1917, 1996.
S. DM, “Clinical correlates of chronic rejection in pediatric renal transplantation: A report of the North American Pediatric Renal Transplant Cooperative Study,”, Transplantation, vol. 61, pp. 1054-58, 1996.
A. Tejani, Cortes, L., and Stablein, D., “Clinical correlates of chronic rejection in pediatric renal transplantation. A report of the North American Pediatric Renal Transplant Cooperative Study.”, Transplantation, vol. 61, no. 7, pp. 1054-8, 1996.